<sup>18</sup>F-FDG PET/CT对非小细胞肺癌纵隔淋巴结转移诊断价值的Meta分析

姚晓龙; 孙灿文; 娜仁花; 何霖; 古丽菲拉·海克甫; 杨小丰; 姚晓龙; 孙灿文; 娜仁花; 何霖; 古丽菲拉·海克甫; 杨小丰

doi:10.3760/cma.j.issn.1673-4114.2018.01.010

[1]

段晓蓓, 樊卫, 许泽清, 等.基于¹⁸F-FDG PET/CT显像分析非小细胞肺癌纵隔淋巴结转移的危险因素[J].中国医学影像技术, 2012, 28(6):1135-1139.
Duan XB, Fan W, Xu ZQ, et al. Analysis of risk factors for mediastinal lymph nodes metastases in non-small cell lung cancer patients with ¹⁸F-FDG PET/CT[J]. Chin J Med Imaging Technol, 2012, 28(6):1135-1139.

[2]

Penny Whiting, Anne WS Rutjes, Johannes B Reitsma, 等. QUADAS的制定:用于系统评价中评价诊断性研究质量的工具[J].中国循证医学杂志, 2007, 7(4):296-306. DOI:10.3969/j.issn.1672-2531.2007.04.009.
Penny WG, Anne WSR, Johannes BR, et al. The development of QUADAS:a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. Chin J Evid-based Med, 2007, 7(4):296-306. doi: 10.3969/j.issn.1672-2531.2007.04.009

[3]

徐白萱, 刘雁翎, 姚树林, 等. FDG PET对非小细胞肺癌纵隔淋巴结分期的价值[J].中国肺癌杂志, 2003, 6(3):198-200. DOI:10.3779/j.issn.1009-3419.2003.03.09.
Xu BX, Liu YL, Yao SL, et al. Value of FDG PET for mediastinal lymph node staging in non-small cell lung cancer[J]. Chin Lung Cancer, 2003, 6(3):198-200. doi: 10.3779/j.issn.1009-3419.2003.03.09

[4]

杨衿记, 吴一龙, 唐安戊, 等. ¹⁸F-FDG PET诊断非小细胞肺癌纵隔淋巴结转移的初步临床研究[J].岭南现代临床外科, 2004, 4(3):215-217. DOI:10.3969/j.issn.1009-976X.2004.03.022.
Yang JJ, Wu YL, Tang AW, et al. The preliminary clinical study of ¹⁸F-FDG PET on diagnosing the metastasis of the mediastinal lymph nodes of NSCLC[J]. Lingnan Mod Clin Surg, 2004, 4(3):215-217. doi: 10.3969/j.issn.1009-976X.2004.03.022

[5]

Halpern BS, Schiepers C, Weber WA, et al. Presurgical staging of non-small cell lung cancer:positron emission tomography, integrated positron emission tomography/CT, and software image fusion[J]. Chest, 2005, 128(4):2289-2297. DOI:10.1378/chest.128.4.2289.

[6]

Kim YK, Lee KS, Kim BT, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated ¹⁸F-FDG PET/CT in a tuberculosis-endemic country:diagnostic efficacy in 674 patients[J]. Cancer, 2007, 109(6):1068-1077. DOI:10.1002/cncr.22518.

[7]

Lee PC, Port JL, Korst RJ, et al. Risk Factors for occult mediastinal metastases in clinical stage Ⅰ non-small cell lung cancer[J]. Ann Thorac Surg, 2007, 84(1):177-181. DOI:10.1016/j.athoracsur.2007. 03.081.

[8]

Hwangbo B, Kim SK, Lee HS, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer[J]. Chest, 2009, 135(5):1280-1287. DOI:10.1378/chest.08-2019.

[9]

Lee JW, Kim BS, Lee DS, et al. ¹⁸F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country:consideration of lymph node calcification and distribution pattern to improve specificity[J]. Eur J Nucl Med Mol Imaging, 2009, 36(11):1794-1802. DOI:10.1007/s00259-009-1155-4.

[10]

李向东, 尹吉林, 柳伟坤, 等. PET/CT对评价非小细胞肺癌纵隔淋巴结转移的诊断价值[J].南方医科大学学报, 2010, 30(3):506-508.
Li XD, Yin JL, Liu WK, et al. Value of positron emission tomography computed tomography in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer[J]. J South Med Univ, 2010, 30(3):506-508.

[11]

Tasci E, Tezel C, Orki A, et al. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer[J]. Interact Cardiovasc Thorac Surg, 2010, 10(2):200-203. DOI:10.1510/icvts.2009.220392.

[12]

Darling GE, Maziak DE, Inculet RI, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer:results of mediastinal staging in the early lung positron emission tomography trial[J]. J Thorac Oncol, 2011, 6(8):1367-1372. DOI:10.1097/JTO.0b013e318220c912.

[13]

Sommer G, Wiese M, Winter L, et al. Preoperative staging of non-small-cell lung cancer:comparison of whole-body diffusion-weighted magnetic resonance imaging and ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography[J]. Eur Radiol, 2012, 22(12):2859-2867. DOI:10.1007/s00330-012-2542-y.

[14]

Saydam O, Gokce M, Kilicgun A, et al. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer[J]. Med Oncol, 2012, 29(2):589-594. DOI:10.1007/s12032-011-9879-y.

[15]

Harders SW, Madsen HH, Hjorthaug K, et al. Characterization of pulmonary lesions in patients with suspected lung cancer:computed tomography versus[¹⁸F]fluorodeoxyglucose-positron emission tomography/computed tomography[J]. Cancer Imaging, 2012, 12(3):437-446. DOI:10.1102/1470-7330.2012.0035.

[16]

Kuo WH, Wu YC, Wu CY, et al. Node/aorta and node/liver SUV ratios from ¹⁸F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma[J]. Acad Radiol, 2012, 19(6):685-692. DOI:10.1016/j.acra.2012.02.013.

[17]

许泽清, 段晓蓓, 樊卫. ¹⁸F-FDG PET/CT显像诊断非小细胞肺癌纵隔淋巴结转移的临床价值[J].中华核医学与分子影像杂志, 2013, 33(5):381-382. DOI:10.3760/cma.j.issn.2095-2848. 2013. 05.016.
Xu ZQ, Duan XB, Fan W. Diagnostic value of ¹⁸F-FDG PET/CT for metastasis of mediastinal lymph nodes in non-small-cell lung cancer patients[J]. Chin J Nucl Med Mol Imaging, 2013, 33(5):381-382. doi: 10.3760/cma.j.issn.2095-2848.2013.05.016

[18]

Koksal D, Demirag F, Bayiz H, et al. The correlation of SUV_max with pathological characteristics of primary tumor and the value of tumor/lymph node SUV_max ratio for predicting metastasis to lymph nodes in resected NSCLC patients[J]. J Cardiothorac Surg, 2013, 8(1):63. DOI:10.1186/1749-8090-8-63.

[19]

Billè A, Okiror L, Skanjeti A, et al. The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients:analysis of 413 cases.[J]. Clin Lung Cancer, 2013, 14(2):149-156. DOI:10.1016/j.cllc.2012.04.007.

[20]

Booth K, Hanna GG, Mcgonigle N, et al. The mediastinal staging accuracy of ¹⁸F-fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery[J]. Ulster Med J, 2013, 82(2):75-81.

[21]

Li S, Zheng Q, Ma Y, et al. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT[J/OL]. Plos One, 2013, 8(10): e78552-e78552[2017-05-03]. http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0078552&tpe=printable. DOI: 10.1371/journal.pone.0078552.

[22]

Xu ZQ, Xie L, Fan W, et al. Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT[J]. Nucl Med Commun, 2014, 35(5):466-471. DOI:10.1097/MNM.0000000000000077.

[23]

Moloney F, Ryan D, McCarthy L, et al. Increasing the accuracy of ¹⁸F-FDG PET/CT interpretation of 'mildly positive' mediastinal nodes in the staging of non-small cell lung cancer[J]. Eur J Radiol, 2014, 83(5):843-847. DOI:10.1016/j.ejrad.2014.01.016.

[24]

黄占文, 陈跃, 蔡亮, 等. ¹⁸F-FDG PET/CT在非小细胞肺癌纵隔淋巴结转移的诊断价值[J].泸州医学院学报, 2015, 38(4):368-370. DOI:10.3969/j.issn.1000-2669.2015.04.012.
Huang ZW, Chen Y, Cai L, et al. Role of ¹⁸F-FDG PET/CT in the evaluation of mediastinal lymph node metastasis of non-small cell lung cancer[J]. J Luzhou Med Coll, 2015, 38(4):368-370. doi: 10.3969/j.issn.1000-2669.2015.04.012

[25]

白璐, 于楠, 李艳, 等.基于¹⁸F-脱氧葡萄糖PET-CT成像对非小细胞肺癌纵隔淋巴结转移识别的Meta分析[J].中华放射学杂志, 2016, 50(10):752-757. DOI:10.3760/cma.j.issn.1005-1201. 2016.10.005.
Bai L, Yu N, Li Y, et al. The value of ¹⁸F-FDG PET-CT in the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer:a Meta-analysis[J]. Chin J Radiol, 2016, 50(10):752-757. doi: 10.3760/cma.j.issn.1005-1201.2016.10.005

[26]

张召奇, 赵新明, 王建方, 等. ¹⁸F-FDG PET/CT诊断非小细胞肺癌纵隔淋巴结转移[J].中国医学影像学杂志, 2014, 22(4):293-296. DOI:10.3969/j.issn.1005-5185.2014.04.014.
Zhang ZQ, Zhao XM, Wang JF, et al. ¹⁸F-FDG PET/CT in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer[J]. Chin J Med Imaging, 2014, 22(4):293-296. doi: 10.3969/j.issn.1005-5185.2014.04.014